Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01467843 · ClinicalTrials.gov registry record · Phase 3
Comparison of CAM and Conventional Mind-Body Therapies for Chronic Back Pain
A Phase 3 study of Low Back Pain, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 3
- Development phase
- 342
- Enrollment target
- 1
- Study location
NCT01467843 is a Phase 3 study of Low Back Pain that has completed, run by Kaiser Permanente. The registered enrollment target is 342 participants, below the 501-participant average among 122 other Low Back Pain trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01467843, a Phase 3 study of Low Back Pain, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 342 participants
- Enrollment target
- 1
- Study location
Study Summary
Although national expenditures on back pain treatments have increased substantially over the past decade, the health and functional status of persons suffering from back pain has deteriorated. This trial will evaluate the effectiveness, and cost-effectiveness, of a safe and relatively inexpensive "mind-body" therapy that has the potential to provide relief to some of the millions of Americans who continue to suffer from chronic back pain.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Mindfulness Based Stress Reduction
Study Locations (1)
Washington
- Group Health Cooperative - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01467843
The ClinicalTrials.gov registry entry for NCT01467843 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 501-participant average among 122 other Low Back Pain trials with a reported enrollment target (32% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01467843 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01467843 about?
NCT01467843 is a clinical study titled "Comparison of CAM and Conventional Mind-Body Therapies for Chronic Back Pain". Although national expenditures on back pain treatments have increased substantially over the past decade, the health and functional status of persons suffering from back pain has deteriorated. This trial will evaluate the effectiveness, and cost-effectiveness, of a safe and relatively inexpensive "m...
What is the current status of trial NCT01467843?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 342 participants. The study started on 2012-06. Estimated completion is 2015-11.
What conditions does trial NCT01467843 study?
This clinical trial studies the following conditions: Low Back Pain.
What interventions are being tested in trial NCT01467843?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Mindfulness Based Stress Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT01467843?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01467843 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
RECRUITING · Phase 3
-
The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain
COMPLETED · Phase 3
-
Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
COMPLETED · Phase 3
-
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
COMPLETED · Phase 3
-
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects
COMPLETED · Phase 3
-
Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.